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Pin1 is a Prolyl Isomerase that catalyzes cis-trans isomerization of peptides with
pSer/Thr-Pro motifs in many cell signaling proteins. This conformational switch is
implicated in diseases. Pin1 activity is considered a target for therapeutic applications.
Pin1 targets motifs by its N-terminal WW-binding domain. A C-terminal PPIase domain
is responsible for catalysis. To understand how Pin1 coordinates its enzymatic activities,
it is necessary to probe how the domains behave in the presence of substrates.
Here, we used novel (Histone H1 and Sic1) and other existing peptides to characterize the
dynamics of Pin1 and impact of substrate binding on inter-domain interactions. Pin1peptide complexes have been used to show that peptide addition causes a conformational
change in the two domains.
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N-relaxation data suggest that the flexibility of these

domains depends on the substrate peptide We have constructed a hypothesis about which
substrate residues may be important for conferring tight binding and inter-domain
interactions.
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CHAPTER I
INTRODUCTION

Brief introduction to Pin1
Pin1 is an essential Peptidyl-prolyl isomerase (PPIase) from a family of highly
conserved proteins which encompasses; the cyclophilins, FK506-binding proteins and
parvulins.1 This is a family of proteins that recognize only phospho-proteins and rapidly
catalyze proline (Pro) amide bonds of substrates, between cis and trans configurations
(Figure 1.1) and induce conformational changes in their substrates.2,3 This conformational
switch results in alternation of substrate protein structure and/or function, changes in
protein stabilization, and subsequent implications in some human diseases. Pin1 has been
reported to be involved in Alzheimer’s, asthma, and cancer.4-6 Substrate recognition by
this protein is via its short N-terminal domain which associates with phosphorylated
serine (Ser) or threonine (Thr) residues, referred to as the WW domain, while the Cterminal (PPIase) does the catalysis. A short flexible linker separates the two domains.
Interestingly, both WW and PPIase domains recognize similar pSer/pThr-Pro motifs.7,8 ,9

1

Cis
O
N

O

Pin1
O

Trans

P

O

O

NH
NH3

O

COO

H3C

N

NH3

NH

O

O

P
O

O
O

Figure 1.1

COO

O

H3 C

Pin 1 catalyzes cis-trans isomerization backbone ω- bond angle (red) of a
pSer-Pro-Ala tripeptide.

Pin1 was originally identified as a cell cycle protein. Consequently, many cell
cycle regulation proteins have been identified as potential Pin1 substrates. The increasing
number of potential binding partners for Pin1 has made it difficult to decipher its role in
the pathogenesis of human diseases. Pin1 binding has been found to activate, degrade,
and or stabilize its substrate proteins. Most studies on Pin1’s role in cancer biology
suggest that Pin1 is either positively or negatively involved in cancer.10 Lu and coworkers reported that inhibition of Pin1 leads to mitotic entry, chromatin condensation
and mitotic catastrophe.7,11 Overexpression of Pin1 has also been reported to act as a
negative regulator of mitosis since it is able to prevent overexpression of the Never In
Mitosis protein (NIMA), a known cause of premature chromatin condensation which
leads to cell death.12 Addition of Pin1to egg extracts has been observed to inhibit mitotic
entry in Xenopus laevis.11,13,14
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Binding and subsequent isomerization of pSer/Thr-Pro motifs distinguishes Pin1
from other cyclophilins and FK506-binding proteins in the PPIase family of proteins.
This isomerization process represents an important event in the eukaryotic cell cycle
regulated by kinases such as cyclin dependent kinases (CDK’s).8,12,15 CDK’s work to
phosphorylate substrates in a configuration-specific manner. Transferring a gamma
phosphate from ATP to desired substrate is necessary for Pin1 binding, yet it is reported
to slow down the already prolonged isomerization of Ser/Thr-Pro bonds,15,16 and
renders the phosphopeptide bond resistant to cyclophilin, FKBP or parvulin catalysis.15,17
Pin1’s regulatory functions in the cell cycle include: DNA damage responses,
transcription, splicing, and germ cell development.2,12,13,15,18 Pin1’s involvement in the
above processes suggests that its deregulation might contribute to disease in humans.
Indeed, Pin1 is overexpressed in many tumors and its overexpression generally correlates
with poor clinical outcome.5,19,20 With increasing experimental observations regarding the
function of Pin1 in cancer, the possibility that Pin1 can either function as a tumor
promoter or tumor suppressor is still a controversial topic.
Enzymatic activity of Pin1 is further implicated in pathogenesis of Alzheimer’s
disease (AD), a neurodegenerative disease characterized by the presence of plaques and
tangles.21 Pin1 reacts with phospho-proteins that are similar to the ones interacting with
phosphorylation-specific monoclonal antibody mitotic phospho-protein monoclonal-2
(MPM-2), which strongly interacts with mitotic protein extracts and with neurofibrillary
tangles (NFTs) and neurons in the brains of AD patients.22
The presence of cell division cycle (Cdc)-2 kinase phosphorylating Ser/Thr-Pro
motifs during pre-mitotic/mitotic (G2/M) phases of the cell cycle parallels with
3

predominantly hyperphosphorylated Tau proteins in AD brains, whiles a normal tau
protein is triply phosphorylated.23 Pin1 is expressed mainly in neuronal soluble fractions
in a healthy brain, however, it is co-localized with NFTs leading to the depletion of
soluble Pin1in AD brains.12,19,24 Studies have shown that Pin1-/- mice develop progressive
age-dependent neuropathy which is characterized by tau hyper-phosphorylation and
filament formation, Amyliod Precursor Protein (APP) amyloidogenesis, intracellular
Aβ42 accumulation and neuronal degeneration (figure 1.2).25,26

APP

Tau

trans pAPP

trans pTau

Pin1
cis pAPP

cis pTau

A beta 42 overexpression

Tau Aggregation

Plaques

Tangles

Alzheimer's
Disease

Figure 1.2

The Role of Pin1 in Alzheimer’s disease

Note: Down-regulation and modification of Pin1 decreases the rate of isomerization in
peptide which may lead to amyloidogenic pathway in APP. In the case of Tau protein,
decreased isomerization may promote accumulation of hyperphosphorylated forms,
inducing formation of NFT observed in AD.
Moreover, Pin1 has been implicated in remodeling (the development of diseases
associated with structural changes in airways such as asthma). Persistent asthma is
characterized by chronic pulmonary inflammation, leading to airway fibrosis.
4

Inflammations are caused by excessive release of profibrotic cytokines from Eos –
derived (TGF-β1) and T-cells.27,28
Post- translational modification of Pin1
Post-translational modification is the covalent attachment of functional groups to
proteins; these modifications can lead to proteolytic cleavage of regulatory subunits, or
they can alter the structure of an entire protein. Post-translational modifications serve to
increase the functional diversity of proteome. Some examples of these covalent
modifications include phosphorylation, acetylation, glycosylation, ubiquitination, and
oxidation. Phosphorylation and oxidation have been reported to play important roles in
cellular signal transduction pathways.3,7 Pin1 phosphorylation by cAMP-dependent
Protein Kinase A (PKA) at Ser-16, located at the binding pocket in the WW domain, has
been reported to inhibit substrate interaction leading to decrease in isomerase activity in
mitotic cell extracts.6 On the other hand, Pin1 dephosphorylation at mitotic phase leads to
Pin1 diffusion in the entire cell. The PPlase domain was also reported to be modified by
Polo-like kinase1 (Plk-1) phosphorylation.29 Ser-65 is mainly phosphorylated within the
PPlase catalytic domain. This modification however does not inhibit Pin1 catalytic
activity but enhances its stability; the extent to which the enzyme can be degraded is
regulated by this process. It can be inferred that Plk-1 overexpression might contribute to
tumorigenisis by stabilizing Pin1, leading to upregulation of Pin1 oncogenetic
substrates.29 Also, the Pin1S67E mutant, containing glutamate to mimic phosphorylated
Ser67 induces complete loss in Pin1 activity; this shows that the Ser67 proceeding Arg68
and Arg69 involved in pSer/Thr motif targeting is essential for recognizing the catalytic
transition state of Pin1-substrates.3
5

Oxidation is marked by the presence of carbonyl containing compounds like
adehydes and ketones which are generated from oxidative cleavage of proteins via the
alpha-amidation pathway, or by Michael addition of alpha-beta unsaturated aldehydes.
An accumulation of protein carbonyls results in protein dysfunction diseases.30 A
consequence of oxidation is exhibited in AD brains, leading to imbalance in the systemic
amount of reactive oxygen species (ROS) and how much ROS the biological system can
readily detoxify. Proteomics studies by Sultana et al. revealed that Pin1 is subjected to in
vivo oxidative modification in AD hippocampus, suggesting that oxidative modification
is related to the reported loss of Pin1 isomerase activity which is crucial for the
neurofibrillary pathology of AD.31 Oxidation might serve as a chemotherapeutic target
against cancer due to its ability to inactive Pin1’s activity.
Pin1 as a molecular timer
While many controversies remain about the role of Pin1 in human disease, it is
becoming clear that pSer/pThr motifs play a crucial role in the regulation of catalysis.
When the cis or trans form of a particular substrate in the cell is depleted by processes
such as isomer-specific degradation or dephosphorylation, equilibrium is quickly restored
by Pin1. This process is naturally slow in the absence of a PPIase. Pin1 however does not
shift the cis/trans equilibrium of the substrate. It can only maintain equilibrium
populations of targeted cis and trans substrate conformations on the millisecond
timescale relevant for regulation of dynamic biological processes.32
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Structure of Pin1
As described previously, there are two distinct domains in Pin1. The short N
terminal WW domain is similar to Src homology3 (SH3) domains and many
evolutionally and functionally diverged proteins. WW domain is one of the smallest yet
most versatile protein-protein interaction modules comprising of approximately 35 amino
acids in a stable fold. It derives its name from two tryptophan (W) residues spaced about
20-22 amino acid residues apart. Anti-parallel beta sheets are the dominant secondary
structural motifs in this domain, three of which are found with limits regulated by the two
invariant tryptophan residues, one near each terminus. Within the core are conserved
aromatic residues, mainly tyrosine (Tyr) and C-terminal to the second W is the highly
conserved proline (Pro). Conserved aromaticity is key to proline-ligand specificity of
WW domain interactions. WW-ligand interactions are further strengthened by conserved
hydrophobic interactions with histidine (His) at the active site.8,33
The C-terminal domain of Pin1 comprises the essential PPlase domain, which is
responsible for catalysis and regulation of cell cycle proteins.12 Proline amide bond
catalysis by PPIase domain may accelerate the folding and trafficking of mitochondrial
precursor proteins. PPIase activity increases the ability of productive folding to compete
with aggregation by rapid binding of Hsp60s and Hsp70s chaperones, while rapid prolyl
isomerase activity accelerates productive folding.34 There are approximately 118 residues
in the C-terminal PPIase domain, consisting of four scaffolding alpha helices surrounding
a flattened half- beta barrel and four-stranded anti-parallel beta sheets, the first helix
contributes nine residues to form the opposing wall of the interdomain cavity of largely
hydrophobic composite surface while catalytic conserved residues, Leu122, Met130, and
7

Phe134 project outward from the barrel structure and serve as proline binding pocket.8
Residues Lys63, Arg68, and Arg69 form a positively charged phosphate- binding loop to
coordinate the pSer/Thr motif, as shown in the figure below.35

Figure 1.3

Crystal structure of Pin1 (2ITK)

Note: WW domain (red) with 2 Trp residues in magenta. PPIase domain (gray), with
residues His59, His64, Lys63, Arg68, and Arg69 of the catalytic loop shown in sticks.

Pin1 binding models
Three models have been proposed to explain how the two Pin1 domains
coordinate binding and isomerization of substrates. First, and consistent with multiply
8

phosphorylated substrate, is the sequential model, which is based on the apparent
difference in substrate binding affinities between the two domains. This model proposes
that the WW domain must either bind and release to make way for the PPIase domain
binding and subsequent isomerization or remain bound, allowing the PPIase domain to
act on one or more sites in the same substrate.2 Second is the multimeric binding model,
where a substrate is phosphorylated and isomerized by two members of the same
complex and the domains bind separately but not simultaneously to two phosphorylated
sites on a substrate. The local concentrations of PPIase must be higher in this case.9 The
third model is the catalysis-first binding model, which proposes that PPIase domain is
required to create WW domain binding sites. This model is based on the fact that all
reported structures of WW domain substrate binding are in the trans conformation,36
hence the PPIase isomerizes a cis substrate to trans form, creating more WW domain
binding sites. An implication of this model is that WW domain will sequester the pool of
trans-substrate and hinder PPIase catalysis.37 Figure 1.4 below shows the three proposed
Pin1 binding models.

9

Figure 1.4

Proposed binding models of Pin1, adapted from Innes, et al.37

Structural analysis
Structure-based drug design has become a promising method to develop treatment
for diseases. There is the need to understand how their structure correlates to their
functions to further understand how biomolecules are involved in diseases and their
treatments. Structural activity relationships (SAR) in a particular protein have practical
applications in molecular disease diagnosis and treatment. Specific ligands are designed
to react with particular protein substrate involved in a particular molecular disease.
Protein three-dimensional structure and dynamics can give information about the
mechanism of the protein function. X-ray crystallography and Nuclear Magnetic
Resonance (NMR) spectroscopy have emerged as powerful techniques for investigating
biomolecular structure and dynamics. NMR is becoming more popular since analysis can
10

be done in solutions which are closer to physiological conditions. However, several
limitations complicate NMR-based analysis: NMR is typically limited to smaller
proteins, and these proteins must retain high solubility in low-salt conditions. Hence,
NMR is considered complementary to X-ray structure determination.38
Much attention has been focused on characterizing protein dynamics in the
microsecond and millisecond timescales (102 - 106 sec-1). These rates coincide with rates
of many biological processes such as ligand binding, protein folding and enzymes
catalysis.39 Slow time scale interconversions are identified by NMR as distinct
resonances. Cis and trans forms of particular nuclei can be seen as separate resonances
on the NMR. Unlike other techniques, NMR experiments have the ability to measure
isomerization at chemical equilibrium, removing the need to perturb the cis-trans
equilibrium and take time resolved datasets. Carr-Purcell Meiboom-Gill (CPMG)
relaxation dispersion,40 or NMR spin relaxation in the rotating frame (R1ρ )41 experiments
can measure the catalyzed rate of exchange as well as the rates and populations of onenzyme motions. Transverse relaxation optimized spectroscopy (TROSY) experiments
can be used as a tool for lineshape analysis. TROSY spectra can yield information about
kinetics, populations, and unobservable chemical shifts on residue specific basis.42
In this work we seek to investigate the impact of peptide binding on the interdomain motion of the two domains of Pin1. We investigated domain-domain interactions
with standard NMR methodology. Different substrates have been added to full length
Pin1 to investigate how the two domains behave in the presence of a specific peptide
fragment.

11

We investigated the extent to which Pin1 interacts with phosphoshorylated
substrates; Histone H1.4 (H1.4 PO3), Histone H1.5 (H1.5 PO3), Sic 1_69 PO3, Sic1_ 80
PO3 and Sic 69-PO3 via TROSY and 1H-15N titrations. Here, different titration points
corresponding to different concentrations were collected and was then fitted to obtain
dissociation constants (KD) for all the Pin1-ligand interactions.
Relaxation data were collected for peptides that showed tighter binding with Pin1;
those with lower KD values. Interdomain interactions have been determined under
solution conditions by chemical shift mapping. Overall correlations were estimated from
15

N spin relaxation data.
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CHAPTER II
MATERIALS AND METHODS

This chapter briefly introduces the theories of Nuclear Magnetic Resonance
(NMR); the major technique used in this work, and ultraviolet-visible (UV-Vis)
spectroscopy. Additionally, the experimental details employed in studies of Pin1 are fully
described.
NMR is a powerful nondestructive analytical tool that is used to determine
molecular structure including relative configuration, relative and absolute concentrations,
and intermolecular interactions of an analyte. NMR results from the absorption of
magnetic energy by a nucleus as it changes its spin in a magnetic field. Only nuclei with
nonzero spin numbers are detected by this technique; examples of such nuclei include:
13

C, 1H, 2H, 19F, 15N, and 31P. Protons (1H) are the most studied among all other nuclei

and their resonance spectrum is characteristic of the particular analyte being examined.
Properties of analytes can be examined via through-bond spin-spin couplings (J) and
through-space nuclear Overhauser effects (NOE).43 When 1H with a spin quantum
number of ½ is placed in an external magnetic field B0, there will be two possible
orientations of the dipole axis quantized orientation by 2I+1, where I is the nuclear spin
quantum number. The image below shows the possible quantized orientation of spinning
1

H nuclei.
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Figure 2.1

The behavior of a charged nucleus in a magnetic field

Note: A spinning charge generates a magnetic dipole m. (b) The dipole takes two
allowed orientations in the magnetic field. (c) The energy level of m depends on the field
strength. Adapted from Ho et al.43
The component of magnetic dipole in the z direction is given by
ħ

where

(2.1)

is the gyromagnetic ratio for the specific nucleus, ms is the spin quantum

number which can be -½ when the dipole is against the field or +½ when it is with the
field and ħ is defined as Planck’s constant (h) divided by 2π. The energy difference
between the 2 levels in diagram c is given by:
2

ħ

(2.2)

Transitions between these energy levels results in NMR signal at a particular frequency,
given by;
/2
γ
14

(2.3)

Modern NMR instruments are designed to work in the Fourier Transform (FT)
unlike continuous wave approach. Here, both imaginary (y) and real (x) channels are
involved in pulsing and detection. In FT NMR instruments, a constant field from a
magnet and a radio frequency pulse are simultaneously irradiated on to the sample to
cause nuclear transition. This causes excited nuclei to precess around z-axis and return to
thermal equilibrium. A time domain emission signal is recorded by the instrument as the
nuclei relax. A frequency domain spectrum is obtained by Fourier transformation.43
Figure 2.2 below shows a schematic diagram of the FTNMR instrument.

Figure 2.2

A schematic diagram of an FT NMR instrument.44

Most NMR work on biological molecules uses nuclei with ½ spin system since
they produce spectra that are greatly simplified. 1D 1H NMR techniques can give
information about protons present in amino acids. It gives characteristic resonances
resulting from alpha protons and others in the side chain. Even though this spectrum is
informative, it becomes complex and impossible to interpret as the number of spin
15

systems increase with larger biomolecules. Multidimensional NMR techniques are
capable of probing larger molecules which cannot be studied with 1D NMR. These
techniques require many separate 1D spectra to be recorded, changing the evolution time
in the indirect dimension for each 1D spectra. Using multidimensional methods, it is
possible to easily measure dipole-dipole transfer (NOE) and scalar couplings (J).
UV absorbance is another useful nondestructive technique for quantifying and
identifying an analyte based on absorbance of ultraviolet light. This technique is based on
Beer’s law; A=ε×b×c. The law states that the absorption of light is proportional to the
concentration c, and the path length b, where the molar absorptivity coefficient ε, is the
proportionality constant specific to every analyte. All samples in this work were
quantified by HP 8452 UV-vis spectrophotometer (refurbished by Olis, Inc.). Absorbance
was recorded at 280 nm where Trp and Tyr residues have significant absorbance. At the
same time, 260 nm was monitored to ensure low concentrations of DNA relative to
protein The molar extinction coefficient of Pin1 protein is 20,970 M-1cm-1 for both the
His-tagged and cleaved forms.45
Experimental details
All solutions were prepared with 18.2 MΩ MilliQ water purified by ELGA
ultrapurification systems and highest grade commercially available chemicals were used.
Pin1 protein expression
The ampicillin resistant pJex404 plasmid encoding His-tagged human Pin1 was
purchased from DNA 2.0 (Menlo Park, CA). The plasmid was transformed via heat shock
into competent E. coli BL21 (star) DE3 (Invitrogen) cells. A single colony was used to
16

inoculate a 1L M9 minimal media (using 18.7 mM 15NH4Cl with 100 µg/ml ampicillin).
Cultures were grown at 37˚C to 0.6 OD600, and expression was induced with 1 mM
isopropylthio-β-galactoside (IPTG). Cells were incubated overnight at room temperature
overnight. Cells were harvested by centrifugation at 8,000 x g for 20 min. Harvested cells
were resuspended in 40 mL lysis buffer (150 mM NaCl, 20 mM HEPES pH 7.5, 20 mM
Imidazole, 5 mM BME, 0.5 mg/mL lysozyme, plus a tablet of protease inhibitor).
Resuspended cells were sonicated on ice in a Branson sonicator at power level 4 (2 min.
continuous pulse, 2 min. rest). Insoluble proteins and DNA were pelleted out by
centrifuging at 18,000 x g for 45 minutes and the clarified lysate was applied to a 5 mL
Nickel His Trap FF column attached to a an AKTA FPLC (GE).
The column was washed with 25 mL wash buffer A (150 mM NaCl, 20 mM
HEPES pH 7.5, 20 mM Imidazole and 5mM BME). Bound protein was eluted with 60
mL linear gradient of elution buffer B ( 150mM NaCl, 20 mM HEPES pH 7.5, 800 mM
Imidazole, 5mM BME), uncleaved protein was quantified and 1U/mg thrombin was
added to Pin1 and dialyzed overnight at 4°C in 1 L dialysis buffer (150mM NaCl, 20 mM
HEPES pH 7.5, 20mM Imidazole, 5mM BME). Benzamidine sepharose (0.5 mL) was
equilibrated in dialysis buffer and added to the dialyzed Pin1 protein. After rocking on
the ice for 30 min., the protein sample was centrifuged at 3,800 x g for 10 min. to remove
the beads. The supernatant was loaded back on to the HisTrap FF column. The flow
through, containing purified Pin1, was further purified by gel filtration on a HiLoad
26/600 Superdex 75pg column, equilibrated with gel filtration column buffer (50mM
NaCl, 20 mM NaH2PO4 pH 6.8, 5 mM EDTA, 0.5 mM DTT,0.02 % NaN3). Below is a
schematic diagram of cell lysate preparation.
17

Figure 2.3

Lysate preparation

Phospho-peptide resuspension
All phospho-peptides (containing pSer/Thr motif) used in this work were
purchased from GenScript (Piscataway, NJ). They were initially resuspended in water to
concentrations higher than 15 mM. After a few titration points were collected, the pH of
the Pin1 NMR sample was observed to have changed. It then became necessary to ensure
that both phospho-peptide and Pin1 have the same pH since the small amounts of peptide
can dramatically affect the pH of NMR samples. Acetone was then used to precipitate out
the resuspended peptide. Cold acetone of about 4X the volume of peptide was added to
peptide in a polypropylene tube and stored at -20˚C for 1 hr. Acetone was allowed to dry
18

out at room temperature, leaving solid peptide which was then resuspended in gel
filtration column buffer. Peptides were quantified by UV absorbance at 280 nm, using
theoretical extinction coefficient of 5500 cm-1M-1 provided by the manufacturer, in
cases where extinction coefficient were not available, estimates from the ExPASy
ProtParam website were used.
Table 2.2

Peptide fragments used in this work
Peptide
CTD PO3
H1.4 PO3
H1.5 PO3
Sic1_68 PO3
Sic1_80 PO3
Pintide PO3

Sequence
YpSPTpSPSW
KATGAApTPKKSAKW
KVAKpSPKKAKAW
SNMGTpSPFNGLTW
TSQRpSPFPKSSW
EWFYpSPFLE

NMR experiments and data analysis
All experiments were carried out at 298 K on Bruker AVANCE III 600 MHz
spectrometer, equipped with multinuclear biomolecular (QCI) probe for observation of
1

H while decoupling 13C, 15N, and/or 31P. Spectra were processed and analyzed with

nmrPipe tools, nmrDraw,46 and Sparky. Sine-squared weighting functions (apodization)
were applied to Free Induction Decays (FIDs) to improve the signal to noise ratio. Peak
heights and positions were obtained from the sparky’s peak detection module.
Titration experiments
Pin1-peptide binding studies were used to measure KD.
1

H-15N TROSY spectra47 were recorded for a set of successively concentrated

samples. 50 µM of unlabeled peptide was first added to 75 µM 15N labeled full-length
19

Pin1. Titration points were taken at peptide concentrations of; 0 µM, 50 µM, 100 µM,
200 µM, 400 µM and 600 µM. Two dimensional 1H-15N TROSY spectra, with 20.7 kHz
(12.3 kHz) spectral width in f2 (f1) and 256 (2464) complex data points was collected for
each concentration of added peptide. A total of 32 scans were acquired per FID with 2.0 s
interscan delay, resulting in a total time of 5 hrs per experiment. Chemical shift values
were obtained from previous assignments.9 The chemical shift perturbations were
calculated using the equation below.
∆

0.17∆

√ ∆

(2.4)

The observed chemical shift perturbations for individual residues were fitted to equation
4 below with in-house fitting scripts to obtain dissociation constants of the proteinpeptide interactions.

↔

(2.5)

(2.6)
∆

∆

(2.7)

Where [complex] can be calculated from:
∆

(2.8)
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P0 is the total Pin1 concentration, L0 is the total peptide concentration, P and L are the
respective initial concentrations of Pin1 and peptide, Δδf is the difference between free
and bound states, and KD is the dissociation constant.
Relaxation is a powerful technique used to obtain backbone amide1H-15N NOE,
Heteronuclear longitudinal relaxation (15N R1), Heteronuclear transverse relaxation
(15N R2) data. NMR samples were prepared such that they were at least 90 % saturated.
The apo-Pin1 relaxation data was collected on 350 µM, 100 mM NaCl, 5mM DTT and 6
% D2O. The table below shows the protein-peptide concentrations for all substrate
peptides used.
Table 2.3

Pin1-peptide ratios used for relaxation experiment

Estimated
fractional
saturation
CTD PO3
2.1
350
0.99
Pintide PO3
2.5
350
0.96
H1.4 PO3
3.0
350
0.95
Sic1_80 PO3
4.5
200
0.9
Note: All samples had the same concentration of salt, DTT, and D2O as apo-Pin1.
Fraction bound was pre-estimated based on KD obtained from titration experiments.
Peptide

Peptide concentration
(mM)

Pin1 concentration
(µM)

HSQC relaxation experiments were used to collect 15N T1 and 15N T1ρ decays at 7
and 6 time points respectively (T1 delays = 100, 300, 500, 700, 800, 900, and 1000 ms ;
T1ρ = 5, 35, 65, 85, 95, 105 ms) with duplicate spectra. A total of 3000 and 3584
Complex points were collected at 2 kHz spin lock power for 15N T1 and 15N T1ρ
respectively. Individual residue 15N T1 and 15N T1ρ decays were obtained from Sparky
peak integration and further converted to 15N R1 and 15N R2 based on the equations 5.28
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in Cavanagh, et al.48 The 1H-15N Heteronuclear NOE was measured to determine the
extent to which polarization can be transferred from the backbone proton to amine
nitrogen bound to it. Spectra were collected on same samples as above. Data heights were
obtained from Sparky peak lists and then fitted to single experiment decay to obtain
(R2obs). Out of 163 amino acid residues, data for an average of 145 residues was
collected on Pin1 complexes.
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CHAPTER III
RESULTS AND DISCUSSION

Titrations and chemical shift perturbation mapping
Chemical exchange occurs when a dynamic process takes a given nucleus from
one magnetic environment to another where there are differences in its NMR parameters
such as; chemical shift, scalar coupling, dipolar coupling, and relaxation rate. This
process is only visible via NMR since there are no signs of reaction in the lab scale.
Chemical exchange can either be intramolecular (folding and unfolding of proteins,
tautomerization, side chain interaction) or intermolecular (ligand binding, isotopic
exchange, enzyme catalysis).
A system can undergo slow, intermediate, or fast exchange processes. The effects
of relatively slow exchange (on the spin-lattice relaxation timescale) on lineshape are not
obvious, yet it can greatly affect relaxation experiments. On the other hand, intermediate
exchange processes cause resonances to coalesce and manifest as broad peaks
representing a weighted average of two individual states, with short spin-spin relaxation
values.49 A third form of exchange is the fast exchange. This occurs at a different NMR
time regime from coalescence. Here, a single Lorentzian peak is observed. The rate of
exchange between the two spin systems are far greater than the chemical shift difference
between the two spins (kex>> |Δδ|). Figure 3.1 below illustrates these three forms of
chemical exchange processes.
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Figure 3.1

The three forms of chemical exchange

Note: Slow exchange, mainly occur in tight binding, intermediate exchange, and fast
exchange found, found primarily in weak binding.Where δA and δB correspond to
chemical shifts of nuclei populations A and B respectively, kA and kB are the rate
constants for conversion from population A to B respectively, and kex is the exchange rate
between the two populations (for two-state exchange,
). Adapted from
Mittermaier, et al.50
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The addition of peptide to protein causes a change in the magnetic environment of
residues leading to a peak shift and broadening in lineshape in both dimensions of
1

H-15N TROSY spectra and can yield information on specific-residue chemical

perturbations.42
Pin1- phospho-peptide interactions have been previously studied by Verdecia et
al. via fluorescence anisotropy. The N-termini of a set of Pro-Xaa-pSer/pThr-Pro motifs
were tagged with rhodamine to monitor flourescence. Where Xaa can be any other amino
acid besides Gly. Interestingly low KD values (in the ranges of 5-80 µM) were
reported51. In 2007, Labeikovsky and co-workers probed the interaction between PPIase
Pin1 and WFYpSPRLKK substrate using 15N HSQC NMR titration. The PPIase domain
was used since authors were primarily interested in catalysis. The reported KD for the
PPIase domain was 0.80 ± 0.15 mM.39 Prior to this work, Jacobs et al. had similarly
reported KD values of 200-400 µM, 200 µM, and 117 µM for YpSPTpSPS,
EQPLpTPVTDL, and WFYpSPR respectively.9 Isothermal Titration Calorimetry (ITC)
has also been used to determine the thermodynamic properties of PPIase Pin1 with its
substrate–analogue inhibitor Ac-Phe-D-Thr-(PO3H2)-Pip-Na1-Gln-NH2. Pin1 was
reported to have very high affinity (0.018 µM KD) for the substrate inhibitor.52
In this work the KD of Pin1-phosphopeptide complexes has been measured using
similar approaches to Labeikovsky et al. and Verdecia et al. on successively concentrated
samples. Figure 3.2 below shows a subset overlaid spectra for the individual titration
points collected. The effects of peptide addition are visualized by a change in resonance
position of an original peak indicated in red. The extent to which a particular peak shifts
gives an idea of the extent of binding interactions between the residue and added peptide.
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We observed chemical shift changes in almost all the residues in WW domain and a few
residues found in the PPIase domain, mainly at the active site of the enzyme and those at
the back of the WW domain.
All backbone amide resonances move progressively as single peaks for every
titration point collected. This is an indication of a fast-to-intermediate exchange process;
where the protein and protein-ligand intermediate coalesce into a single intense proteinligand complex. Moreover, the presence of a single peak upon peptide addition also
indicates that all peptides are weak binders, the bound state peaks are short-lived and do
not appear as additional low intensity peaks. This condition allows for calculation of
dissociation constant with fast exchange equation 2.8.
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Figure 3.2

Overlay of I5N TROSY spectra of a 75 µM 15N Pin1- Peptide titration, with
varying amounts of unlabeled H1.4 PO3 peptide

Note: 75 µM 15N Pin1- Peptide is titrated with varying amounts of unlabeled H1.4 PO3
from 0 µM (red), 50 µM (orange), 100 µM (yellow), 200 µM (green), 400 (blue), and
600 µM (purple).
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Figure 3.3

Overlay of I5N TROSY spectra of 75 µM 15N Pin1- Peptide titration, with
varying amounts of unlabelled peptides

Note: H1.4 PO3 (a), H1.5 PO3 (b), Sic1_80 PO3 (c), and Sic1_69 PO3 (d); from 0 µM
(red), 50 µM (orange), 100 µM (yellow), 200 µM (green), 400 µM (blue), and 600 µM
(purple). Expanded regions above each spectrum shows how residue Gly20 is perturbed.

Chemical shift values were extracted from these spectra and the changes were
calculated using equation 2.4 to obtain chemical shift perturbation as a function of
residue number, as shown in Figure 3.3 below. Obviously, most of the residues in the
WW domain had the highest chemical shift perturbation, and those in the linker region
experienced barely any perturbation. Virtually all the residues in PPIase domain are
weakly perturbed. We found that all the peptides studied cause relatively strong
perturbations in WW domain. This observation supports the fact that the WW domain is
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the substrate targeting domain and peptide binding is associated with changes in the
chemical environment of the residues in that domain. The few perturbations in PPIase
domain could also support the fact that the PPIase domain is also involved in phosphatedirected substrate targeting but its affinity is 10 times lower than WW domain.15 This
pattern is similar to that observed by Labeikovsky et al. and supports the conserved WW
domain-peptide interactions hypothesized by Wintjens.36 The few perturbations between
residues 60-70 are mainly due to the triad of basic residues, Lys63, Arg68, and Arg69
which define the entrance of PPIase domain’s active site.53
In Figure 3.4, we mapped the Chemical shift perturbations on to the PDB
structure reported by Zhang et al. (2ITK), and observed that the most affected domain is
the WW domain and the residues located in β7 and ɑ4 of PPIase domain, which is similar
to the active site reported in the PDB structure 2ITK.53
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Figure 3.4

Pin1-Peptide Chemical Shift Perturbation Plot

Note: A plot of 15N chemical shift differences between Pin1-H1.4 PO3 (black), Pin1-H1.5
PO3 (red), Pin1-Sic1_80 PO3 (violet), and Pin1-Sic1_69 PO3 (blue). Empty spaces are
unassigned residues.
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Figure 3.5

Mapping of chemical shift perturbations onto PDB structure, 2ITK.

Note: (a) H1.4 PO3, (b) H1.5 PO3, (c) Sic1_80 PO3, and (d) Sic1_69 PO3. Perturbations
were mostly observed in and at the backside of WW domain, and also correspond to the
reported in the PDB structure as peptide binding site.

Intermediate-to-fast exchange associated with Pin1 and its substrates results in a
single peak which allows for estimation of the dissociation constants of the individual
peaks. In Figure 3.5 below, three residues from each 15N TROSY spectra were fit to a
binding curve of change in chemical shift as a function of substrate concentration. The
plots show that H1.4 PO3 gets saturated faster relative to the other substrates. In the case
of H1.5 PO3, the delta values continue to rise even after 8-fold concentration of peptide
was added. Sic1_80 PO3 and Sic1_69 PO3 are intermediate cases between a relatively
high affinity substrate (H1.4 PO3) and low affinity substrate (H1.5 PO3).
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The various peptides studied in this work have been listed in table 3.10 below, the
differences in KD is mainly based on the sequence and pH of the solution. KD values were
in the hundreds. Our newly identified Histone H1.4 PO3 peptide has binding affinity is
quite similar to the pintide sequence we used. Our pintide however, has weaker affinity
compared to that reported by Verdecia et al. This could be due to the difference in pH,
our titrations were performed around pH 6.8, compared to 7.5 in the Verdecia et al. work.
Pin1 activity has been reported to be dependent on the ionization state of the
phosphorylated side chains.51 Very high association constants have been reported for
Pin1 and substrate inhibitor at pH of 8 and 9 using ITC.52 Besides changing the ionization
states of the substrate peptide side chains, the phosphate group itself can be protonated by
abundant protons in an acidic solution rendering Pin1’s substrate targeting and
subsequent isomerization inefficient Lower binding affinity observed for H1.5 PO3 could
be due to more positive residues N-terminal to proline. Pin1 substrate specificity is not
only dependent on phosphate ions, but also on the set of positively charged basic residues
that open the active site. Lys63 and Arg69 modulates the specificity of anionic/acidic
residues.8,52
Moreover, CTD PO3 peptide recorded the highest affinity among all the 6
peptides we studied. This could be due to the presence of two phosphate groups.
Comparing the values reported for mono and di phosphorylated CTD PO3 from Verdicia
et al.50 it was deduced that high binding affinity is could be an additive effect from the
WW domain binding the two phosphates, or the two domains separately binding to the
two phosphate groups as described in the multimeric binding model in chapter I.37,51 In
the case of Sic1_69 PO3 and Sic1_80 PO3, the slightly higher affinity of Sic1_80, may be
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due to the presence of more bulky aromatic side chains, which could be accomodated in
Pin1’s greasy pocket (Leu122, Ala124, Phe125, and Met130).52

Figure 3.6

A subset of residues exhibiting chemical shift as a function of substrate
concentration in 15N Pin1-Substrate titrations

Note: (a) H1.4 PO3, (b) H1.5 PO3, (c) Sic1_80 PO3, and (d) Sic1_69 PO3
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Table 3.1

Average KD’s of peptides

Peptide

Reference

Sequence

KD (µM)

CTD PO3

This work

YpSPTpSPSW

7±3

CTD-S2/S5 PO3

Verdecia et al.51

YpSPTpSPS

10.0 ± 0.9

pintide PO3

Verdecia, et al.51

WFYpSPFLE

17 ± 2

pintide PO3

This work

EWFYpSPFLE

30 ± 11

CTD-S5 PO3

Verdecia, et al.51

YSPTpSPS

30 ± 4

H1.4 PO3

This work

KATGAApTPKKSAKW

38 ± 11

Sic1_80 PO3

This work

TSQRpSPFPKSSW

160 ± 70

Sic1_69 PO3

This work

SNMGTpSPFNGTW

170 ± 30

H1.5 PO3

This work

KVAKpSPKKAKAW

>350

Note: Our KD values have been corrected (by a factor of 3.5) based on the pH
dependence (between 6.8 and 7.5) of the association constant (KA) for Pin1 at 293 K
reported by Daum et al.52

Changes in dynamics upon substrate binding
Protein dynamics can be modeled at the picoseconds to nanosecond timescale by
measuring site specific observables such as longitudinal recovery rate (R1), transverse
relaxation rate (R2), and 15N-1H heteronuclear nuclear Overhauser effect (HetNOE).54
Measuring R1 and R2 values involves collecting a series of experiments at different time
points to quantify the time dependent buildup or decay of longitudinal and transverse
magnetizations respectively, while HetNOE is dependent on the ratio of signals with and
without proton presaturation.
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To understand how Pin1 functions in the presence of its substrates, we have
quantified site specific motions via the three NMR experiments indicated above and the
results are shown in Figures 3.6-3.9. A plot of HetNOE versus the residue the Figure 3.6
indicates that protein is not entirely rigid and that both domains tumble somewhat
independently. This is evident from the different sets of data points obtained for residues
in the WW and PPIase domains. An 15N NOE value close to 0.824 (at 600MHz) is an
indication of stable structure exhibiting highly restricted internal motions, values lower
than 0.65 are indicative of substantial internal motions, and negative values represent
completely disordered motions.9
It can be inferred from the above statements and Figure 3.7 below that Pin1 has
two stable domains which are connected by a highly flexible linker. NOE values for the
domains are not significantly affected by addition of substrate peptides; peptide addition
does not change the stability of individual domains, the linker remains flexible upon
peptide addition. The cartoon above the NOE plot shows that the linker remains flexible
even when the two domains are bound. This could mean that it loosely connects the WW
and PPIase domains and could also explain why the PDB structure does not show
electron density for linker region in the X-ray structural analysis.
R1 values increase with faster tumbling of nuclei whereas R2 values increase with
slower tumbling. Figure 3.8 shows that addition of CTD PO3, pintide PO3, and Sic1_80
PO3 decreases R1. H1.4, on the other hand, tumbles similarly to the apo-Pin1 R2 values
for CTD PO3, pintide PO3, and Sic1_80 PO3 are higher than those recorded for apo-Pin1
and H1.4 samples (Figure 3.9). The difference in R1 and R2 values buttress the point that
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inter-domain association varies as a function of peptide. Comparing the R2 values of
PPIase to WW in all cases indicates that PPIase tumbles more slowly than WW.
The apparent size of the complex appears to change as a particular peptide is added.
It can be deduced that the flexibility of the two domains is highly modulated by
presence of substrate phospho-peptide used in this study in the order: H1.4 PO3
< Sic1_80 PO3 < CTD PO3 < pintide PO3. Similar behavior was observed by Jacobs et al.
for a somewhat different set of peptides.9 It can be observed from Figure 3.8 that pintide
PO3 and CTD PO3 induce strong interactions in two domains that are capable of causing
both of them to tumble virtually at the same rate as a single rigid molecule (there are no
significant differences in R2 values between WW and PPIase domains). Nonetheless, we
observed that the Sic1 data has WW domain R2 values that are quite lower than those for
the PPIase domain. This could be as a result of the weaker interaction induced by
Sic1_80 PO3 binding. We expected H1.4 PO3 to behave similarly to pintide peptide since
they have similar KD values; however H1.4 PO3 relaxes similarly to apo-Pin1 in all cases.
This may indicate that not all tight binders could induce significant conformational
change within the two domains.
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or

Figure 3.7

A plot of 15N Heteronuclear NOE vs. Residue number
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Figure 3.8

A plot of 15N longitudinal recovery rate (R1) against individual residue
numbers, R1 is an inverse of Spin-lattice relaxation (T1).

Note: These values and R2 (figure 3.7) were calculated based on the equation 5.28 of
Cavanagh, et al.48
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Figure 3.9

A plot of 15N transverse relaxation rate (R2) against individual residue
numbers.

We estimated rotational diffusion times (τc) of each peptide interaction from
R2/R1 ratio and extrapolated to 600 MHz 15N Relaxation parameter curve reported by
Cavanagh et al. shown in figure 3.9.48 The R2/R1 ratio was used instead of the individual
values since this ratio is independent to a first approximation of site-specific variations in
local fast dynamics (S2).55 Our values have been compared to those reported by Jacobs et
al in table 3.2. It can be observed that τc values are similar for apo-Pin1. The difference in
internal motions between Jacobs et al. pintide and ours could be due to the sequence. The
primary sequence of pintide according to Verdicia et al. is quite different from the
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sequence Jacobs used. They also reported that their peptides had limited solubilities. This
could limit the extent to which binding sites are saturated resulting in smaller relaxation
effects.
It can also be seen that the peptides with higher binding affinities had higher τc
values when compared to apo-Pin1. Also, the difference in τc values for two domains
means that full length Pin1 does not tumble isotropically as a single rigid sphere.
Table 3.2

Rotational diffusion times (τc) for Pin1-peptide relaxations
Peptide
Peptide

Average R2/R1

τc (ns)

MW
(g/mol)

WW

PPIase

WW

PPIase

1083.9

13.8±0.8

14.3±1.5

11.2±0.2

11.4±0.3

896.0

NA

NA

8.9±0.1

10.8±0.1

pintide PO3

1297.3

15.2±1.3

17.2±1.7

12.0±0.3

12.0±0.3

pintide9 WFYpSPR

934.0

NA

NA

9.9±0.4

11.0±0.1

1524.7

6.6±0.4

11.7±1.0

7.4±0.2

10.3±0.1

CTD PO3

CTD9
YpSPTpSPS

H1.4 PO3
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Sic1_80 PO3
1584.6

6.6±0.4

11.7±1.0

7.4±0.2

10.3±0.1

Apo-Pin1(No Peptide)

-

6.7±0.5

11.0±0.9

7.6±0.1

9.9±0.2

Apo-Pin1 (No Peptide)9

-

NA

NA

7.6±0.2

9.8±0.1

Figure 3.10

15

N Relaxation parameter ratio (R2/R1) vs. Rotational Diffusion time (τc,
ns) at 600 MHz

Note: The equation for this calibration plot was adapted from Cavanagh, et al.48
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CHAPTER IV
CONCLUSIONS

In this work, we have identified four new Pin1 substrates which are also relevant
cell cycle proteins. We also found that our new peptides behave similarly to several
known Pin1 substrates. Correction of our KD values for pH effects, based on the work
done by Daum et al.52 brings our values into agreement with those reported by Verdecia
et al.51 H1.4 has binding affinity close to the pintide sequence we used. The KD value we
recorded is much lower than the KD values reported by Jacobs et al.9
Our analysis demonstrates that Pin1 binding can be modulated by the residues in
peptide fragments. From our results we can confidently say that Pin1 activity is not solely
dependent on pSer/pThr–Pro motif, but also on the groups C and N-terminal to proline in
the substrate. Pin1 prefers more acidic (negative) residues N-terminal to proline and more
hydrophobic residues on C-terminus. While this finding was suggested by Verdecia et al.,
our work is the first to demonstrate the importance of specific residues proximal to the
pSer/pThr-Pro binding site.51 A result of our work is that it is now possible to predict
which substrates will exhibit high-affinity based on a set of simple rules.
We tried to explain Jacobs’ model by using both titration data and relaxation data,
and it was observed that some peptides bind tightly to Pin1 but does not cause two
domains to tumble isotropically in solution as the Jacobs model shows.
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Even though H1.4 PO3 binds tightly to Pin1, it does not cause WW and PPIase domains
to collapse into a single, isotropically-tumbling unit. For this peptide, binding to the WW
domain appears to be tight even though the interdomain interaction is very weak – the
“interaction parameter,” originally proposed by Jacobs, is quite low. Based on this
observation, we could categorize tight binders in two groups; those that cause significant
conformational change in Pin1 (pintide PO3 and CTD PO3) and those that do not
significantly change Pin1 conformation (H1.4 PO3 andSic1_80 PO3). We have also used
relaxation experiments to show that the two domains of Pin1 are loosely connected by the
linker; the flexibility does not depend on the extent of interaction between substrate and
Pin1 protein. At this point, it is unclear why some peptides cause both domains to
collapse and why others do not, although work is ongoing to determine the physical
origins of this behavior.
Finally, we can deduce that the multimeric binding model is not feasible in all
cases. In the presence of peptides that cause significant conformational change
(association) in Pin1, the two domains are so tightly associated after substrate binding
that the PPIase domain might not be able to bind to the second phosphate group on the
substrate. In the case of CTD PO3, when binding and self-association are particularly
tight, the active site may not access the second phosphorylation site while the peptide is
bound. The affinity depends on the second phospho-serine; where the first phosphate is
seen as a negative group N-terminal to the proline preceding the second phospho-serine
group.
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Table A.1
Peptide

CTD PO3

A complete list of residues used for τc estimation
WW

Residues used
PPIase

10,11,12,13,20, 54,64,65,67,68,78,79,83,84,87,88,92,93,95,98,104,105,10
21,22,23,24,25, 6,108,116,117,118,121,124,125,127,128,129,134,135,136
32,33,36
1137,138,139,140,158,160,161,163

12,13,14,16,20, 54,55,56,60,61,63,65,67,68,8182,89,90,93,95,98,101,112,
pintide PO3 2122,23,25,26,3 114,119,124,128,132,135,138,142,143,148,152,159,161,1
1,32,33,35,3638
63
H1.4 PO3

57,58,59,60,61,65,66,67,80,8182,84,85,87,88,90,93,95,98,
11,12,14,15,20,
101,103,105,106,109,110,111,113,114,115,116,118,120,1
22,23,25,26,31,
21,123,126,127,128,129,134,134,135,136,1137,138,139,1
32,33,35,36
41,142,144,145,147,148,151,154,158,160,161,163

53,54,55,56,57,58,59,60,62,63,64,66,79,81,83,84,85,87,88
12,13,15,21,22,
,90,91,93,94,95,99,102,103,104,105,106,108,111,113,117,
Sic1_80 PO3 23,25,30,31,32,
118,119,121,123,127,128,129,134,135,136,138,140,141,1
33,35,36
43,144,146,146,147,151,152,157,158,160,161,163
57,58,59,60,61,63,66,67,83,84,85,87,88,90,91,92,93,94,95
12,13,14,16,21,
,99,102,103,104,105,106,108,111,113,117,118,119,127,12
apo-Pin
22,23,30,31,32,
8,129,134,135,136,1137,138,139,140,141,142,144,150
33,35
151,157,158,160,161,163
Note: Residues were selected on the basis of average R1, R2, and high NOE values.
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